First Wave BioPharma (FWBI) Stock Analysis

What First Wave BioPharma does

First Wave BioPharma, Inc. is a biopharmaceutical company in the clinical development phase, concentrating on the research and creation of specialized, non-systemic treatments for various gastrointestinal conditions. The company's therapeutic pipeline centers on two main compounds: 1. Niclosamide: An oral small molecule recognized for its antiviral and anti-inflammatory properties. Programs utilizing niclosamide include: FW-COV, currently undergoing Phase II trials for gastrointestinal infections caused by SARS-CoV-2. FW-UP (Phase II) and FW-UC (Phase Ib/IIa), both targeting ulcerative proctitis and ulcerative proctosigmoiditis. FW-ICI-AC, designed to treat colitis and diarrhea linked to immune checkpoint inhibitors in advanced cancer patients. FW-CD, which has successfully completed Phase I clinical trials for Crohn's disease. 2. Adrulipase: A biologic, recombinant lipase enzyme formulated as an oral, non-systemic capsule. Its purpose is to assist in the digestion of fats and other nutrients, with development focused on treating exocrine pancreatic insufficiency (EPI) in patients afflicted with cystic fibrosis and chronic pancreatitis. Originally founded in 2014, the company operated as AzurRx BioPharma, Inc. until it adopted the name First Wave BioPharma, Inc. in September 2021. The firm's headquarters are located in Boca Raton, Florida.

Key metrics

ETFs linked to FWBI

Broad-market and Healthcare sector ETFs an investor holding First Wave BioPharma is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how FWBI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for First Wave BioPharma?

First Wave BioPharma trades under the ticker FWBI on NASDAQ.

Which exchange is FWBI listed on?

FWBI is listed on NASDAQ.

What sector does First Wave BioPharma operate in?

First Wave BioPharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze FWBI in a portfolio?

PortView shows FWBI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.